Impact of hypertension on various markers of subclinical atherosclerosis in early type 2 diabetes

Journal of Diabetes and Metabolic Disorders

Volumn 13, Issue 1, 2014, Pages

  Alatab, Sudabeh ^a   Fakhrzadeh, Hossein ^a   Sharifi, Farshad ^a   Mostashfi, Ali ^b   Mirarefin, Mojde ^a   Badamchizadeh, Zohreh ^a   Tagalizadehkhoob, Yaser ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Khatamolanbia Hospital   (Iran)

Author keywords

ABI; CIMT; Diabetes melitus; FMD; Hypertension; Subclinical atherosclerosis

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; SUGAR; TRIACYLGLYCEROL;

ADULT; AGE; ANKLE BRACHIAL INDEX; ANTHROPOMETRY; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; FEMALE; FLOW MEDIATED DILATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL;

EID: 84908177511     PISSN: None     EISSN: 22516581     Source Type: Journal    
DOI: 10.1186/2251-6581-13-24     Document Type: Article

References (29)

1. Fakhrzadeh H, Bandarian F, Adibi H, et al. Coronary heart disease and associated risk factors in Qazvin: a population-based study. East Mediterr Health J 2008, 14:33-41.
2. Booth GL, Kapral MK, Fung K, Tu JV. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 2006, 368:29-36. 10.1016/S0140-6736(06)68967-8, 16815377.
3. Ali YS, Rembold KE, Weaver B, et al. Prediction of major adverse cardiovascular events by age-normalized carotid intimal medial thickness. Atherosclerosis 2006, 187:186-190. 10.1016/j.atherosclerosis.2005.09.003, 16233899.
4. Yeboah J, Folsom AR, Burke GL, et al. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 2009, 120:502-509. 10.1161/CIRCULATIONAHA.109.864801, 2740975, 19635967.
5. Resnick HE, Lindsay RS, McDermott MM, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the strong heart study. Circulation 2004, 109:733-739. 10.1161/01.CIR.0000112642.63927.54, 14970108.
6. Papamichael CM, Lekakis JP, Stamatelopoulos KS, et al. Ankle-brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease. Am J Cardiol 2000, 86:615-618. 10.1016/S0002-9149(00)01038-9, 10980210.
7. Wadwa RP. Noninvasive measures of cardiovascular changes in diabetes mellitus. Curr Opin Endocrinol Diab Obes 2007, 14:263-268.
8. Landmesser U, Hornig B, Drexler H. Endothelial function: a critical determinant in atherosclerosis?. Circulation 2004, 109:27-33.
9. Perticone F, Ceravolo R, Pujia A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001, 104:191-196. 10.1161/01.CIR.104.2.191, 11447085.
10. Fowkes FGR, Murray GD, Butcher CL, et al. Ankle brachial index collaboration, ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008, 300:197-208. 2932628, 18612117.
11. Stamler J, Neaton JD, Wentworth DN. Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension 1989, 13(suppl):I 2-I 12.
12. Definition WHO. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of a WHO/IDF Consultation 2006, World Health Organization.
13. National High Blood Pressure Education Program The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Washington, DC, USA: U.S Department of health and human service. National Institutes of Health National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program.
14. Fakhrzadeh H, Alatab S, Sharifi F, et al. Carotid intima media thickness, brachial flow mediated dilation and previous history of gestational diabetes mellitus. J Obstet Gynaecol Res 2012, 38(8):1057-1063. 10.1111/j.1447-0756.2011.01829.x, 22568764.
15. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force. J Am Coll Cardiol 2002, 39:257-265.
16. Brohall G, Odén A, Fagerberg B. Carotid artery intima-media thickness in patients with type 2 diabetes mellitus and impaired glucose tolerance: a systematic review. Diabet Med 2006, 23:609-616.
17. Butt MU, Zakaria M. Association of common carotid intimal medial thickness (CCA- IMT) with risk factors of atherosclerosis in patients with type 2 diabetes mellitus. J Pak Med Assoc 2009, 59:590-593.
18. Tian J, Wen Y, Yan L, et al. Vascular endothelial dysfunction in patients with newly diagnosed type 2 diabetes and effects of 2-year and 5-year multifactorial intervention. Echocardiography 2011, 28:1133-1140. 10.1111/j.1540-8175.2011.01514.x, 21967242.
19. Roussel R, Mohammedi K, Abi Khalil C, Potier L. Use and utility of ankle brachial index in patients with diabetes. Eur J Vasc Endovasc Surg 2011, 41:110-116. 10.1016/j.ejvs.2010.09.020, 21095144.
20. Widener JM. Peripheral arterial disease and disability from NHANES 2001-2004 data. J Vasc Nurs 2011, 29:104-112. 10.1016/j.jvn.2011.06.002, 21867902.
21. Mahfouz RA, Abdou M, Elsaied A, Kandil N. Predictors of subclinical atherosclerosis and incipient myocardial dysfunction in asymptomatic young hypertensive subjects. Euro J Sci Res 2011, 49:28-38.
22. Sorof JM, Alexandrov AV, Cardwell G, Portman RJ. Carotid artery intimal-medial thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics 2003, 111:61-66. 10.1542/peds.111.1.61, 12509555.
23. Zheng L, Hodis HN, Buchanan TA, Li Y, Mack WJ. Effect of antihypertensive therapy on progression of carotid intima-media thickness in patients with type 2 diabetes mellitus. Am J Cardiol 2007, 99:956-960. 10.1016/j.amjcard.2006.10.061, 17398191.
24. Puddu P, Puddu GM, Zaca F, Muscari A. Endothelial dysfunction in hypertension. Acta Cardiol 2000, 55:221-232. 10.2143/AC.55.4.2005744, 11041120.
25. Gnasso A, Irace C, Carallo C, et al. In vivo association between low wall shear stress and plaque in subjects with asymmetrical carotid atherosclerosis. Stroke 1997, 28:993-998. 10.1161/01.STR.28.5.993, 9158640.
26. Androulakis E, Tousoulis D, Papageorgiou N, et al. Inflammation in hypertension: current therapeutic approaches. Curr Pharm Des 2011, 17:4121-4131. 10.2174/138161211798764753, 22204373.
27. Boos CJ, Lip GY. Is hypertension an inflammatory process?. Curr Pharm Des 2006, 12:1623-1635. 10.2174/138161206776843313, 16729874.
28. Prasad N, Kumar S, Singh A, et al. Carotid intimal thickness and flow-mediated dilatation in diabetic and nondiabetic continuous ambulatory peritoneal dialysis patients. Perit Dial Int 2009, 29(Suppl 2):S96-S101.
29. Taniguchi A, Nakai Y, Fukushima M, et al. Ultrasonographically assessed carotid atherosclerosis in Japanese type 2 diabetic patients: role of nonesterified fatty acids. Metabolism 2002, 51:539-543. 10.1053/meta.2002.31970, 11979382.